After an initial 60 weeks on Zepbound at the MTD, participants either continued on the MTD, reduced the dose to 5 mg, or received a placebo
Zepbound's list price is approximately $1,060 per month
You can read the full article at LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept: Cell Metabolism
The Affinity Difference Dedicated Patient Care Coordinators Affinity Whole Health is the only clinic that provides every patient a dedicated Patient Care Coordinator (PCC) for ongoing support
The weekly injection schedule is also tied to the drug's long half-life
Endnotes Adults who say a doctor or health care provider told them they are overweight or obese in the past five years include those who may also have diabetes or heart disease